載入...
Outcomes in Patients with Classic Hodgkin Lymphoma Treated with ABVD: A Single-center Retrospective Study
OBJECTIVE: Classic Hodgkin lymphoma (CHL) has been regarded as a curable disease when treated appropriately, especially in younger patients, and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) has been regarded as the standard regimen. However, a relatively poor prognosis has been report...
Na minha lista:
| 發表在: | Intern Med |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Japanese Society of Internal Medicine
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7990646/ https://ncbi.nlm.nih.gov/pubmed/33087662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5004-20 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|